Literature DB >> 1442504

Cardiac manifestations of the antiphospholipid syndrome.

S D Kaplan1, E K Chartash, R A Pizzarello, R A Furie.   

Abstract

The antiphospholipid syndrome has been associated with multiple cardiac abnormalities. The earliest reports were of valvular disease, including verrucous endocarditis, as well as valvular thickening and insufficiency. Subsequently, antiphospholipid antibodies were implicated in coronary artery disease manifested by premature myocardial infarction and coronary artery bypass graft occlusion. In addition, there have been rare reports of intracardiac thrombi and diffuse cardiomyopathy in association with antiphospholipid antibodies. In this review, we discuss the nature and prevalence of the cardiac manifestations of the antiphospholipid antibody syndrome as well as some of the proposed pathophysiologic mechanisms. We also provide examples from our own experience. The expanding spectrum of cardiac disease associated with antiphospholipid antibodies suggests an important role for these antibodies in certain types of cardiac pathology.

Entities:  

Mesh:

Year:  1992        PMID: 1442504     DOI: 10.1016/0002-8703(92)90420-z

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Aortic valve replacement for aortic regurgitation in a patient with antiphospholipid antibody syndrome.

Authors:  Nozomu Sasahashi; Hisao Harada; Yoshiaki Saji; Akira Marui; Takeshi Nishina; Masashi Komeda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-07

2.  Presentation, management and outcomes of thrombosis for children with cardiomyopathy.

Authors:  Brian W McCrindle; Tara Karamlou; Harvey Wong; Nirupama Gangam; Kalyani R Trivedi; Kyong-Jin Lee; Lee N Benson
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

3.  Co-existing Bilateral Pulmonary Embolism and Intra-cardiac Mass: A Case of Catastrophic Antiphospholipid Syndrome-like Disease.

Authors:  Huma Zahid; Saira Hassan; Salma Gul; Komal Rizwan; Saif Ullah Khan; Maaz A Maghazi
Journal:  Cureus       Date:  2018-10-10

4.  Left ventricular thrombi in a patient with the antiphospholipid syndrome.

Authors:  D Bruce; D Bateman; R Thomas
Journal:  Br Heart J       Date:  1995-08

5.  M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome.

Authors:  N Coudray; D de Zuttere; O Blétry; J C Piette; B Wechsler; P Godeau; J C Pourny; Y Lecarpentier; D Chemla
Journal:  Br Heart J       Date:  1995-11

6.  Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction.

Authors:  C Raghavan; J Ditchfield; R J Taylor; M R Haeney; P C Barnes
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

Review 7.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

8.  Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature.

Authors:  Spyridon Arampatzis; Ioannis Stefanidis; Vassilios Lakiopoulos; Luigi Raio; Daniel Surbek; Markus G Mohaupt
Journal:  Thromb J       Date:  2010-06-17

9.  Cardiac manifestations of rheumatological conditions: a narrative review.

Authors:  Mohammad Bagher Owlia; Seyed Mohammad Yousof Mostafavi Pour Manshadi; Nafiseh Naderi
Journal:  ISRN Rheumatol       Date:  2012-10-17

10.  Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis.

Authors:  Maria Mialdea; Shirish R Sangle; David P D'Cruz
Journal:  J Autoimmune Dis       Date:  2009-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.